143 related articles for article (PubMed ID: 33812644)
1. Influence of selective acid-etching on functionality of halloysite-chitosan nanocontainers for sustained drug release.
Jauković V; Krajišnik D; Daković A; Damjanović A; Krstić J; Stojanović J; Čalija B
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112029. PubMed ID: 33812644
[TBL] [Abstract][Full Text] [Related]
2. Natural halloysite nanotubes /chitosan based bio-nanocomposite for delivering norfloxacin, an anti-microbial agent in sustained release manner.
Barman M; Mahmood S; Augustine R; Hasan A; Thomas S; Ghosal K
Int J Biol Macromol; 2020 Nov; 162():1849-1861. PubMed ID: 32781129
[TBL] [Abstract][Full Text] [Related]
3. Design of Etched- and Functionalized-Halloysite/Meloxicam Hybrids: A Tool for Enhancing Drug Solubility and Dissolution Rate.
Friuli V; Urru C; Ferrara C; Conti DM; Bruni G; Maggi L; Capsoni D
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543233
[TBL] [Abstract][Full Text] [Related]
4. Halloysite clay nanotubes as a ceramic "skeleton" for functional biopolymer composites with sustained drug release.
Abdullayev E; Lvov Y
J Mater Chem B; 2013 Jun; 1(23):2894-2903. PubMed ID: 32260855
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Characterization of Carvedilol-Etched Halloysite Nanotubes Composites with Enhanced Drug Solubility and Dissolution Rate.
Maggi L; Urru C; Friuli V; Ferrara C; Conti DM; Bruni G; Capsoni D
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110635
[TBL] [Abstract][Full Text] [Related]
6. PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19.
Jermy BR; Ravinayagam V; Almohazey D; Alamoudi WA; Dafalla H; Akhtar S; Tanimu G
Appl Clay Sci; 2022 Jan; 216():106333. PubMed ID: 34776567
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy.
Li W; Liu D; Zhang H; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA
Acta Biomater; 2017 Jan; 48():238-246. PubMed ID: 27815166
[TBL] [Abstract][Full Text] [Related]
8. Halloysite nanotubes in analytical sciences and in drug delivery: A review.
Fizir M; Dramou P; Dahiru NS; Ruya W; Huang T; He H
Mikrochim Acta; 2018 Jul; 185(8):389. PubMed ID: 30046919
[TBL] [Abstract][Full Text] [Related]
9. Faster Release of Lumen-Loaded Drugs than Matrix-Loaded Equivalent in Polylactic Acid/Halloysite Nanotubes.
Venkatesh C; Clear O; Major I; Lyons JG; Devine DM
Materials (Basel); 2019 Jun; 12(11):. PubMed ID: 31195738
[TBL] [Abstract][Full Text] [Related]
10. Preparation of chitosan mesoporous membrane/halloysite composite for efficiently selective adsorption of Al(III) from rare earth ions solution through constructing pore structure on substrate.
Yuan W; Kuang J; Hu H; Ding D; Yu M
Int J Biol Macromol; 2024 Jan; 256(Pt 1):128351. PubMed ID: 37995782
[TBL] [Abstract][Full Text] [Related]
11. Halloysite Nanotubes Coated by Chitosan for the Controlled Release of Khellin.
Lisuzzo L; Cavallaro G; Milioto S; Lazzara G
Polymers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784604
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive micro-composites: Chitosan coated halloysite nanotubes for sustained drug delivery.
Sharif S; Abbas G; Hanif M; Bernkop-Schnürch A; Jalil A; Yaqoob M
Colloids Surf B Biointerfaces; 2019 Dec; 184():110527. PubMed ID: 31577976
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-Coated Halloysite Nanotubes As Vehicle for Controlled Drug Delivery to MCF-7 Cancer Cells In Vitro.
Nyankson E; Aboagye SO; Efavi JK; Agyei-Tuffour B; Paemka L; Asimeng BO; Balapangu S; Arthur PK; Tiburu EK
Materials (Basel); 2021 May; 14(11):. PubMed ID: 34073202
[TBL] [Abstract][Full Text] [Related]
14. Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.
Ganesh M; Jeon UJ; Ubaidulla U; Hemalatha P; Saravanakumar A; Peng MM; Jang HT
Int J Biol Macromol; 2015 Mar; 74():310-7. PubMed ID: 25557368
[TBL] [Abstract][Full Text] [Related]
15. Preparation of palladated porous nitrogen-doped carbon using halloysite as porogen: disclosing its utility as a hydrogenation catalyst.
Sadjadi S; Malmir M; Lazzara G; Cavallaro G; Heravi MM
Sci Rep; 2020 Feb; 10(1):2039. PubMed ID: 32029834
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and characterization of chitosan, polyvinylpyrrolidone, and cellulose nanowhiskers nanocomposite films for wound healing drug delivery application.
Hasan A; Waibhaw G; Tiwari S; Dharmalingam K; Shukla I; Pandey LM
J Biomed Mater Res A; 2017 Sep; 105(9):2391-2404. PubMed ID: 28445626
[TBL] [Abstract][Full Text] [Related]
17. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
18. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and characterization of polymer-ceramic nanocomposites containing drug loaded modified halloysite nanotubes.
Ghaderi-Ghahfarrokhi M; Haddadi-Asl V; Zargarian SS
J Biomed Mater Res A; 2018 May; 106(5):1276-1287. PubMed ID: 29314595
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
